IMV (NASDAQ: IMV)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of IMV (NASDAQ: IMV) through any online brokerage.
There are no as such competitors for IMV.
The latest price target for IMV (NASDAQ: IMV) was reported by Cantor Fitzgerald on Wednesday, September 22, 2021. The analyst firm set a price target for 4.00 expecting IMV to rise to within 12 months (a possible 492.77% upside). 1 analyst firms have reported ratings in the last year.
The stock price for IMV (NASDAQ: IMV) is $0.6748 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for IMV.
IMV’s Q2 earnings are confirmed for Wednesday, August 10, 2022.
There is no upcoming split for IMV.
IMV is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.